Skip to main content

Table 3 Down-regulated miRNAs (n=27) reported in at least two expression profiling studies

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

miRNA name

Studies with same direction (reference)

No. of tissue samples tested

Mean fold-change

Mean rank

hsa-miR-217

AE, AS, NA, NB, YN

371

18.16

4.20

hsa-miR-148a

AE, AS, MB, NA, NB

371

8.03

7.00

hsa-miR-375

AE, AS, MB, NA, NB

371

4.86

9.40

hsa-miR-216b

AS, NA, NB, YN

363

53.44

6.25

hsa-miR-216a

AS, NA, NB, YN

363

30.17

2.25

hsa-miR-130b

AE, AS, NA, NB

310

6.17

12.25

hsa-miR-141

NB, SZ, AE, AS

170

2.81

15.25

hsa-miR-30a-3p

NA, NB, AE

212

2.71

30.67

hsa-miR-200c

AE, AS, NB

150

2.66

23.67

hsa-miR-30a-5p

AS, NB, AE

150

2.16

27.67

hsa-miR-29c

AE, AS, NB

150

1.94

27.33

hsa-miR-30d

AE, AS, NB

150

1.73

35.33

hsa-miR-30e

AS, NB, AE

150

1.57

38.30

hsa-miR-379

SZ, AE, AS

122

1.62

21.67

has-miR-193b-3p

NA, NB

208

6.67

20.50

hsa-miR-184

AS, YN

159

2.82

26.50

hsa-miR-338-5p

AS, NB

142

3.15

25.50

hsa-miR-182

AE, AS

102

2.88

15.50

hsa-miR-30b

AE, AS

102

2.25

17.00

hsa-miR-335

AE, AS

102

2.16

15.00

hsa-miR-200a

AE, AS

102

1.66

24.50

hsa-miR-200b

AE, AS

102

1.62

28.00

hsa-miR-30c

AS, AS

98

2.18

17.00

hsa-miR-148b

AE, MB

73

2.52

2.50

hsa-let-7f

AE, SA

37

13.05

20.00

hsa-let-7c

AE, SA

37

2.66

23.50

hsa-let-7b

AE, SA

37

1.97

25.00